Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Antimicrobial Tolerance and Metabolic Adaptations in Microbial Biofilms

    Research output: Contribution to journalReviewResearchpeer-review

  2. Interactions in multispecies biofilms: do they actually matter?

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The in vivo biofilm

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Ribavirin inhibition of cell-culture infectious hepatitis C genotype 1-3 viruses is strain-dependent

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Genome Sequence of an Unknown Subtype of Hepatitis C Virus Genotype 6: Another Piece for the Taxonomic Puzzle

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Virus Adaptation and Selection Following Challenge of Animals Vaccinated against Classical Swine Fever Virus

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. HCV p7 as a novel vaccine-target inducing multifunctional CD4+ and CD8+ T-cells targeting liver cells expressing the viral antigen

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Genetic recombination is an important evolutionary mechanism for RNA viruses. The significance of this phenomenon for hepatitis C virus (HCV) has recently become evident, with the identification of circulating recombinant forms in HCV-infected individuals and by novel data from studies permitted by advances in HCV cell culture systems and genotyping protocols. HCV is readily able to produce viable recombinants, using replicative and non-replicative molecular mechanisms. However, our knowledge of the required molecular mechanisms remains limited. Understanding how HCV recombines might be instrumental for a better monitoring of global epidemiology, to clarify the virus evolution, and evaluate the impact of recombinant forms on the efficacy of oncoming combination drug therapies. For the latter, frequency and location of recombination events could affect the efficacy of multidrug regimens. This review will focus on current data available on HCV recombination, also in relation to more detailed data from other RNA viruses.

Original languageEnglish
JournalTrends in Microbiology
Volume22
Issue number6
Pages (from-to)354–364
ISSN0966-842X
DOIs
Publication statusPublished - 10 Mar 2014

Most downloaded publications

No data available

ID: 43813418